Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

NAOV

NanoVibronix (NAOV)

NanoVibronix Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:NAOV
일자시간출처헤드라인심볼기업
2024/11/1507:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NAOVNanoVibronix Inc
2024/11/1505:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
2024/11/1222:00Business WireNanoVibronix Provides Business UpdateNASDAQ:NAOVNanoVibronix Inc
2024/10/3005:29Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NAOVNanoVibronix Inc
2024/10/3005:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NAOVNanoVibronix Inc
2024/10/3005:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NAOVNanoVibronix Inc
2024/10/1205:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
2024/10/0921:30Business WireNanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in GermanyNASDAQ:NAOVNanoVibronix Inc
2024/09/2606:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
2024/09/2321:30Business WireNanoVibronix Signs Letter of Intent with Potential New DistributorNASDAQ:NAOVNanoVibronix Inc
2024/08/2121:30Business WireNanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
2024/08/1505:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
2024/05/2221:30Business WireNanoVibronix Announces Commencement of UroShield Clinical Study at the University of MichiganNASDAQ:NAOVNanoVibronix Inc
2024/05/1705:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
2024/05/1621:30Business WireNanoVibronix Issues Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
2024/05/1602:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
2024/05/1421:30Business WireNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldNASDAQ:NAOVNanoVibronix Inc
2024/05/0121:00Business WireNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract AwardNASDAQ:NAOVNanoVibronix Inc
2024/04/0921:30Business WireNanoVibronix Issues Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
2024/03/2821:30Business WireNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldNASDAQ:NAOVNanoVibronix Inc
2024/02/2707:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
2024/02/2409:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
2024/02/2409:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
2024/02/2409:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
2024/02/2409:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
2024/02/1505:45Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NAOVNanoVibronix Inc
2024/01/1806:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NAOVNanoVibronix Inc
2024/01/1806:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
2023/12/1206:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
2023/12/0706:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
 검색 관련기사 보기:NASDAQ:NAOV